Cargando…

Frailty and checkpoint inhibitor toxicity in older patients with melanoma

BACKGROUND: Immune checkpoint inhibitors (ICIs) can cause immune‐related adverse events (irAEs) that range from mild to life‐threatening. Age itself does not seem to be a predictor for the occurrence of irAEs. It is unknown whether frailty plays a role in the occurrence of irAEs. Therefore, the auth...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bruijnen, Cheryl P., Koldenhof, José J., Verheijden, Rik J., van den Bos, Frederiek, Emmelot‐Vonk, Mariëlle H., Witteveen, Petronella O., Suijkerbuijk, Karijn P. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9325486/ https://www.ncbi.nlm.nih.gov/pubmed/35439334 http://dx.doi.org/10.1002/cncr.34230

Ejemplares similares

Biomarkers of Checkpoint Inhibitor Induced Immune-Related Adverse Events—A Comprehensive Review
por: Hommes, Josefien W., et al.
Publicado: (2021)

Immunosuppression for immune-related adverse events during checkpoint inhibition: an intricate balance
por: Verheijden, Rik J., et al.
Publicado: (2023)

Hyperprogressive disease rarely occurs during checkpoint inhibitor treatment for advanced melanoma
por: Schuiveling, M., et al.
Publicado: (2020)

Toxicity, Response and Survival in Older Patients with Metastatic Melanoma Treated with Checkpoint Inhibitors †
por: de Glas, Nienke A., et al.
Publicado: (2021)

Lower risk of severe checkpoint inhibitor toxicity in more advanced disease
por: Verheijden, Rik J, et al.
Publicado: (2020)

Validation of the Dutch version of the Edmonton Symptom Assessment System
por: van der Baan, Frederieke H., et al.
Publicado: (2020)

Added diagnostic value of routinely measured hematology variables in diagnosing immune checkpoint inhibitor mediated toxicity in the emergency department
por: Niemantsverdriet, Michael S. A., et al.
Publicado: (2023)

Highly multiplexed spatial analysis identifies tissue-resident memory T cells as drivers of ulcerative and immune checkpoint inhibitor colitis
por: van Eijs, Mick J.M., et al.
Publicado: (2023)

The impact of frailty on adverse outcomes after transcatheter aortic valve replacement in older adults: A retrospective cohort study
por: Dautzenberg, Lauren, et al.
Publicado: (2022)

Diagnostic pitfalls after COVID-19 vaccination in melanoma and breast cancer patients: A case series
por: de Bock, Ellen, et al.
Publicado: (2022)

Checkpoint inhibitor induced hepatitis and the relation with liver metastasis and outcome in advanced melanoma patients
por: Biewenga, Maaike, et al.
Publicado: (2021)

A Survival Tree of Advanced Melanoma Patients with Brain Metastases Treated with Immune Checkpoint Inhibitors
por: van Not, Olivier J., et al.
Publicado: (2023)

Sex-Based Differences in Treatment with Immune Checkpoint Inhibition and Targeted Therapy for Advanced Melanoma: A Nationwide Cohort Study
por: van der Kooij, Monique K., et al.
Publicado: (2021)

Efficacy and Adverse Events of Immunotherapy with Checkpoint Inhibitors in Older Patients with Cancer
por: van Holstein, Yara, et al.
Publicado: (2019)

Hematologic malignancies following immune checkpoint inhibition for solid tumors
por: van Eijs, Mick J. M., et al.
Publicado: (2022)

Patient-reported outcome measures in a pharmacokinetic study with sunitinib, a prospective cohort study
por: Koldenhof, J. J., et al.
Publicado: (2018)

Switching to Immune Checkpoint Inhibitors upon Response to Targeted Therapy; The Road to Long-Term Survival in Advanced Melanoma Patients with Highly Elevated Serum LDH?
por: Schouwenburg, Maartje G., et al.
Publicado: (2019)

IL7 genetic variation and toxicity to immune checkpoint blockade in patients with melanoma
por: Taylor, Chelsea A., et al.
Publicado: (2022)

Studies on Isolated Tumour Mitochondria: Oxidative Phosphorylation and Fatty Acid Oxidation by Rat Hepatoma Mitochondria
por: Emmelot, P., et al.
Publicado: (1961)

Studies on Isolated Tumour Mitochondria. Phosphate Release from Adenosine Di- and Triphosphates
por: Emmelot, P., et al.
Publicado: (1957)

The Metabolism of Neoplastic Tissues: The Effect of 2:4-Dinitrophenol on the Respiration of Ascites Tumour Cells*,†
por: Emmelot, P., et al.
Publicado: (1959)

The Metabolism of Neoplastic Tissues: The Effect of 2:4-Dinitrophenol on Glycolysis and ATP-Dephosphorylation of Ascites Tumour Cells and Homogenates*,†
por: Emmelot, P., et al.
Publicado: (1959)

Comparison of Different Promoter Methylation Assays in Breast Cancer
por: Suijkerbuijk, Karijn P. M., et al.
Publicado: (2010)

Immune Toxicity with Checkpoint Inhibition for Metastatic Melanoma: Case Series and Clinical Management
por: Lomax, Anna J., et al.
Publicado: (2018)

Long-Term Toxicities of Immune Checkpoint Inhibitor (ICI) in Melanoma Patients
por: Tong, Justin, et al.
Publicado: (2022)

Acute-Onset Pneumonitis while Administering the First Dose of Durvalumab
por: Tonk, Erwin H.J., et al.
Publicado: (2019)

Fatty Acid Oxidation in Normal and Neoplastic Tissues: Enzymatic Activities and Optical Densities of Mitochondrial Suspensions Prepared from Normal and Neoplastic Tissues of the Mouse
por: Emmelot, P., et al.
Publicado: (1956)

Prognostic value of screening instrument based on the Dutch national VMS guidelines for older patients in the emergency department
por: Snijders, B. M. G., et al.
Publicado: (2020)

Age Does Matter in Adolescents and Young Adults versus Older Adults with Advanced Melanoma; A National Cohort Study Comparing Tumor Characteristics, Treatment Pattern, Toxicity and Response
por: van der Kooij, Monique K., et al.
Publicado: (2020)

Nipple Aspirate Fluid at a Glance
por: Patuleia, Susana I. S., et al.
Publicado: (2021)

Accidental falling in community-dwelling elderly with chronic kidney disease
por: Goto, Namiko A., et al.
Publicado: (2018)

Low Levels of BNIP3 Promoter Hypermethylation in Invasive Breast Cancer
por: van Diest, Paul J., et al.
Publicado: (2010)

Systemic Therapy in Advanced Nodular Melanoma versus Superficial Spreading Melanoma: A Nation-Wide Study of the Dutch Melanoma Treatment Registry
por: Rauwerdink, Daan Jan Willem, et al.
Publicado: (2022)

Baseline antibody profiles predict toxicity in melanoma patients treated with immune checkpoint inhibitors
por: Gowen, Michael F., et al.
Publicado: (2018)

Immune Checkpoint Blockade for Metastatic Uveal Melanoma: Re-Induction following Resistance or Toxicity
por: Koch, Elias A. T., et al.
Publicado: (2022)

Frailty is associated with in-hospital mortality in older hospitalised COVID-19 patients in the Netherlands: the COVID-OLD study
por: Blomaard, Laura C, et al.
Publicado: (2021)

Clinical outcome of patients with metastatic melanoma of unknown primary in the era of novel therapy
por: Verver, Danielle, et al.
Publicado: (2021)

Altering microtubule dynamics is synergistically toxic with spindle assembly checkpoint inhibition
por: Schukken, Klaske M, et al.
Publicado: (2020)

Life-space, frailty, and health-related quality of life
por: Chitalu, Petronella, et al.
Publicado: (2022)

Studies on Isolated Tumour Mitochondria: Biochemical Properties of Mitochondria from Hepatomas with Special Reference to a Transplanted Rat Hepatoma of the Solid Type
por: Emmelot, P., et al.
Publicado: (1959)

Cannot write session to /tmp/vufind_sessions/sess_3b1r37vquj27l4o04cc1lkntdg